Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Solid pharmaceutical composition with clopidogrel

A technology of clopidogrel and its composition, which is applied in the field of solid pharmaceutical composition containing clopidogrel and its preparation, and can solve the problems of inability to wet granulation, sticky punching, complicated operation, etc.

Active Publication Date: 2015-05-27
吕霄芳
View PDF22 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0028] This shows, in order to solve the problem of sticking and rushing in the process of preparing clopidogrel bisulfate tablet, and the degradation and the mutarotation problem in the preparation storage process, people have proposed a lot of solutions, but there are certain defects, such as No wet granulation, complex operation, high production cost, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Solid pharmaceutical composition with clopidogrel
  • Solid pharmaceutical composition with clopidogrel
  • Solid pharmaceutical composition with clopidogrel

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 125

[0101] Embodiment 125mg specification clopidogrel tablet preparation

[0102] Composition

Dosage (unit: g)

Clopidogrel hydrochloride (calculated as clopidogrel)

25

Mannitol

70

Crospovidone

6

L-glutamic acid

12

Glyceryl behenate

2.4

Coating agent

Appropriate amount

carnauba wax

Appropriate amount

Approx.

120mg

Co-made

1000 pieces

[0103] The preparation process is as follows:

[0104] 1) Use a dehumidifier to dehumidify the operating space, and control the ambient humidity to less than 20%;

[0105] 2) Take the clopidogrel bulk drug, pulverize it so that the particle size is less than 25 microns, and set aside;

[0106] 3) Take the prescription amount and pulverize the clopidogrel raw material drug, mannitol, and L-glutamic acid, mix evenly, dry granulate, and granulate with a 24-mesh sieve to obtain dry granules containing clopidogrel;

[0107] 4) Take the...

Embodiment 275

[0112] Embodiment 275mg specification clopidogrel tablet preparation

[0113] Composition

Dosage (unit: g)

Clopidogrel hydrochloride (calculated as clopidogrel)

75

Mannitol

135

Crospovidone

13.5

L-glutamic acid

27

Glyceryl behenate

5.4

Coating agent

Appropriate amount

carnauba wax

Appropriate amount

Approx.

270

Co-made

1000 pieces

[0114] The preparation process is as follows:

[0115] 1) Use a dehumidifier to dehumidify the operating space, and control the ambient humidity to less than 20%;

[0116] 2) Take the clopidogrel bulk drug, pulverize it so that the particle size is less than 25 microns, and set aside;

[0117] 3) Take the prescription amount and pulverize the clopidogrel raw material drug, mannitol, and L-glutamic acid, mix evenly, dry granulate, and granulate with a 24-mesh sieve to obtain dry granules containing clopidogrel;

[0118] 4) Take t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

In order to overcome shortcomings of material sticking of a clopidogrel crude drug and hydrolysis of the crude drug in a preparation thereof in storage, the invention designs a solid pharmaceutical composition with clopidogrel and provides a prescription and a process for further preparing the solid pharmaceutical composition into a tablet. The tablet has good forming property and is capable of inhibiting hydrolysis of the crude drug in the process of existence; and unexpectedly, the tablet also inhibits mutarotation of the crude drug. The tablet of the invention is simple in preparation method and can be manufactured by conventional preparation methods without special devices, so that the tablet has the advantages of easy industrialization, high production efficiency, good stability and controllable quality. Thus the solid pharmaceutical composition has outstanding substantive features and obvious inventive steps.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a solid pharmaceutical composition containing clopidogrel, a preparation method and application thereof. Background technique [0002] Cardiovascular and cerebrovascular thrombotic disease is a common disease in my country and an important cause of death for our people. The average incidence of myocardial infarction in my country is about 42 per 100,000 people; and with the improvement of nutritional status, the incidence is increasing. my country is also an area with a high incidence of cerebral thrombosis patients. At present, the number of patients has exceeded 8 million. There are about 1.5 million new cases each year, and more than 1 million deaths each year. Among the survivors, about 25% of them lose their labor force to varying degrees. Among them, severe disability is as high as 40%. Currently, clopidogrel and aspirin are the mainstream drugs for antithromb...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/28A61K31/4365A61K47/26A61K47/32A61K47/18A61K47/14A61P7/02A61P9/10
Inventor 不公告发明人
Owner 吕霄芳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products